Brexpiprazole as an Adjunctive Treatment to Paroxetine or Sertraline in Adult Patients Suffering From Post-traumatic Stress Disorder (PTSD)
Public ClinicalTrials.gov record NCT01987960. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Interventional, Randomised, Double-blind, Parallel-group, Placebo-controlled, Flexible-dose Study of Brexpiprazole as Adjunctive Treatment to Paroxetine or Sertraline in Adult Patients Suffering From Post-traumatic Stress Disorder (PTSD)
Study identification
- NCT ID
- NCT01987960
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- H. Lundbeck A/S
- Industry
- Enrollment
- 417 participants
Conditions and interventions
Conditions
Interventions
- Brexpiprazole Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 30, 2013
- Primary completion
- Sep 30, 2015
- Completion
- Sep 30, 2015
- Last update posted
- Mar 12, 2017
2013 – 2015
United States locations
- U.S. sites
- 22
- U.S. states
- 13
- U.S. cities
- 20
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| US004 | Los Angeles | California | 90024 | — |
| US025 | Los Angeles | California | 90102 | — |
| US024 | Riverside | California | 92504 | — |
| US015 | San Diego | California | 90103 | — |
| US008 | San Diego | California | 92123 | — |
| US002 | Bradenton | Florida | 34201 | — |
| US006 | Gainesville | Florida | 32607 | — |
| US016 | Jacksonville | Florida | 32256 | — |
| US020 | North Miami | Florida | 33161 | — |
| US017 | Tampa | Florida | 33609 | — |
| US012 | Indianapolis | Indiana | 46260 | — |
| US021 | Roslindale | Massachusetts | 02131 | — |
| US019 | Las Vegas | Nevada | 89102 | — |
| US007 | Nashua | New Hampshire | 03060 | — |
| US001 | The Bronx | New York | 10467 | — |
| US009 | Cincinnati | Ohio | 45219 | — |
| US005 | Dayton | Ohio | 45417 | — |
| US010 | Portland | Oregon | 97210 | — |
| US014 | Norristown | Pennsylvania | 19403 | — |
| US011 | Memphis | Tennessee | 38119 | — |
| US003 | Austin | Texas | 78731 | — |
| US026 | Seattle | Washington | 98104 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 37 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01987960, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 12, 2017 · Synced May 7, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01987960 live on ClinicalTrials.gov.